IL1B and metabolic dysfunction-associated steatotic liver disease: In particular, IL-1β has been demonstrated to play a crucial role in MASLD as it activates many diverse liver cells, for example hepatocytes and stellate cells, and plays an important role in the key features of MASLD, such as insulin resistance.